There were reports of increased urinary flow rates and total micturition volumes as well as sexual dysfunction and hyperglycemia.T78
Medrogestone (INN), also known as 6,17?-dimethyl-6-dehydroprogesterone, is a progestational agent derived from 17-methylprogesterone. It was conceived as an alternative for an orally effective contraceptive option.A31526 It was developed by Ayerst, approved in Canada in 1969 and its current status is cancelled post-marketing.L1118 It was never approved by the FDA.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ulipristal | The therapeutic efficacy of Medrogestone can be decreased when used in combination with Ulipristal. |
| Lepirudin | Medrogestone may decrease the anticoagulant activities of Lepirudin. |
| Bivalirudin | Medrogestone may decrease the anticoagulant activities of Bivalirudin. |
| Alteplase | Medrogestone may decrease the anticoagulant activities of Alteplase. |
| Urokinase | Medrogestone may decrease the anticoagulant activities of Urokinase. |
| Reteplase | Medrogestone may decrease the anticoagulant activities of Reteplase. |
| Anistreplase | Medrogestone may decrease the anticoagulant activities of Anistreplase. |
| Tenecteplase | Medrogestone may decrease the anticoagulant activities of Tenecteplase. |
| Abciximab | Medrogestone may decrease the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Medrogestone may decrease the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Medrogestone may decrease the anticoagulant activities of Streptokinase. |
| Dicoumarol | Medrogestone may decrease the anticoagulant activities of Dicoumarol. |
| Ardeparin | Medrogestone may decrease the anticoagulant activities of Ardeparin. |
| Phenindione | Medrogestone may decrease the anticoagulant activities of Phenindione. |
| Fondaparinux | Medrogestone may decrease the anticoagulant activities of Fondaparinux. |
| Pentosan polysulfate | Medrogestone may decrease the anticoagulant activities of Pentosan polysulfate. |
| Dipyridamole | Medrogestone may decrease the anticoagulant activities of Dipyridamole. |
| Heparin | Medrogestone may decrease the anticoagulant activities of Heparin. |
| Enoxaparin | Medrogestone may decrease the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Medrogestone may decrease the anticoagulant activities of Epoprostenol. |
| Coumarin | Medrogestone may decrease the anticoagulant activities of Coumarin. |
| Ximelagatran | Medrogestone may decrease the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Medrogestone may decrease the anticoagulant activities of Desmoteplase. |
| Defibrotide | Medrogestone may decrease the anticoagulant activities of Defibrotide. |
| Ancrod | Medrogestone may decrease the anticoagulant activities of Ancrod. |
| Beraprost | Medrogestone may decrease the anticoagulant activities of Beraprost. |
| Prasugrel | Medrogestone may decrease the anticoagulant activities of Prasugrel. |
| Sulodexide | Medrogestone may decrease the anticoagulant activities of Sulodexide. |
| Semuloparin | Medrogestone may decrease the anticoagulant activities of Semuloparin. |
| Idraparinux | Medrogestone may decrease the anticoagulant activities of Idraparinux. |
| Cangrelor | Medrogestone may decrease the anticoagulant activities of Cangrelor. |
| Astaxanthin | Medrogestone may decrease the anticoagulant activities of Astaxanthin. |
| Apixaban | Medrogestone may decrease the anticoagulant activities of Apixaban. |
| Otamixaban | Medrogestone may decrease the anticoagulant activities of Otamixaban. |
| Amediplase | Medrogestone may decrease the anticoagulant activities of Amediplase. |
| Dabigatran etexilate | Medrogestone may decrease the anticoagulant activities of Dabigatran etexilate. |
| Danaparoid | Medrogestone may decrease the anticoagulant activities of Danaparoid. |
| Dalteparin | Medrogestone may decrease the anticoagulant activities of Dalteparin. |
| Tinzaparin | Medrogestone may decrease the anticoagulant activities of Tinzaparin. |
| (R)-warfarin | Medrogestone may decrease the anticoagulant activities of (R)-warfarin. |
| Nadroparin | Medrogestone may decrease the anticoagulant activities of Nadroparin. |
| Triflusal | Medrogestone may decrease the anticoagulant activities of Triflusal. |
| Ditazole | Medrogestone may decrease the anticoagulant activities of Ditazole. |
| Vorapaxar | Medrogestone may decrease the anticoagulant activities of Vorapaxar. |
| Edoxaban | Medrogestone may decrease the anticoagulant activities of Edoxaban. |
| Sodium citrate | Medrogestone may decrease the anticoagulant activities of Sodium citrate. |
| Dextran | Medrogestone may decrease the anticoagulant activities of Dextran. |
| Bemiparin | Medrogestone may decrease the anticoagulant activities of Bemiparin. |
| Parnaparin | Medrogestone may decrease the anticoagulant activities of Parnaparin. |
| Desirudin | Medrogestone may decrease the anticoagulant activities of Desirudin. |
| Antithrombin Alfa | Medrogestone may decrease the anticoagulant activities of Antithrombin Alfa. |
| Protein C | Medrogestone may decrease the anticoagulant activities of Protein C. |
| Antithrombin III human | Medrogestone may decrease the anticoagulant activities of Antithrombin III human. |
| Letaxaban | Medrogestone may decrease the anticoagulant activities of Letaxaban. |
| Darexaban | Medrogestone may decrease the anticoagulant activities of Darexaban. |
| Betrixaban | Medrogestone may decrease the anticoagulant activities of Betrixaban. |
| Nafamostat | Medrogestone may decrease the anticoagulant activities of Nafamostat. |
| Monteplase | Medrogestone may decrease the anticoagulant activities of Monteplase. |
| Gabexate | Medrogestone may decrease the anticoagulant activities of Gabexate. |
| Protein S human | Medrogestone may decrease the anticoagulant activities of Protein S human. |
| Brinase | Medrogestone may decrease the anticoagulant activities of Brinase. |
| Tioclomarol | Medrogestone may decrease the anticoagulant activities of Tioclomarol. |
| Melagatran | Medrogestone may decrease the anticoagulant activities of Melagatran. |
| Saruplase | Medrogestone may decrease the anticoagulant activities of Saruplase. |
| (S)-Warfarin | Medrogestone may decrease the anticoagulant activities of (S)-Warfarin. |
| Tocopherylquinone | Medrogestone may decrease the anticoagulant activities of Tocopherylquinone. |
| Dabigatran | Medrogestone may decrease the anticoagulant activities of Dabigatran. |
| Argatroban | Medrogestone may decrease the anticoagulant activities of Argatroban. |
| Warfarin | Medrogestone may decrease the anticoagulant activities of Warfarin. |
| Phenprocoumon | Medrogestone may decrease the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Medrogestone may decrease the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Medrogestone may decrease the anticoagulant activities of 4-hydroxycoumarin. |
| Rivaroxaban | Medrogestone may decrease the anticoagulant activities of Rivaroxaban. |
| Ethyl biscoumacetate | Medrogestone may decrease the anticoagulant activities of Ethyl biscoumacetate. |
| Ticagrelor | Medrogestone may decrease the anticoagulant activities of Ticagrelor. |
| Fluindione | Medrogestone may decrease the anticoagulant activities of Fluindione. |
| Clorindione | Medrogestone may decrease the anticoagulant activities of Clorindione. |
| Diphenadione | Medrogestone may decrease the anticoagulant activities of Diphenadione. |
| Troxerutin | Medrogestone may decrease the anticoagulant activities of Troxerutin. |
| Edetic acid | Medrogestone may decrease the anticoagulant activities of Edetic acid. |
| Reviparin | Medrogestone may decrease the anticoagulant activities of Reviparin. |
| Dermatan sulfate | Medrogestone may decrease the anticoagulant activities of Dermatan sulfate. |
| SR-123781A | Medrogestone may decrease the anticoagulant activities of SR-123781A. |
| Human C1-esterase inhibitor | The risk or severity of thromboembolism can be increased when Medrogestone is combined with Human C1-esterase inhibitor. |
| Conestat alfa | The risk or severity of thromboembolism can be increased when Medrogestone is combined with Conestat alfa. |
| Butalbital | The serum concentration of Medrogestone can be decreased when it is combined with Butalbital. |
| Pentobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Pentobarbital. |
| Secobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Secobarbital. |
| Methohexital | The serum concentration of Medrogestone can be decreased when it is combined with Methohexital. |
| Thiopental | The serum concentration of Medrogestone can be decreased when it is combined with Thiopental. |
| Primidone | The serum concentration of Medrogestone can be decreased when it is combined with Primidone. |
| Methylphenobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Methylphenobarbital. |
| Thiamylal | The serum concentration of Medrogestone can be decreased when it is combined with Thiamylal. |
| Phenobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Phenobarbital. |
| Amobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Amobarbital. |
| Hexobarbital | The serum concentration of Medrogestone can be decreased when it is combined with Hexobarbital. |
| Barbital | The serum concentration of Medrogestone can be decreased when it is combined with Barbital. |
| Barbexaclone | The serum concentration of Medrogestone can be decreased when it is combined with Barbexaclone. |
| Butabarbital | The serum concentration of Medrogestone can be decreased when it is combined with Butabarbital. |
| Phenytoin | The serum concentration of Medrogestone can be decreased when it is combined with Phenytoin. |